Rebeccamycin is an antitumor antibiotic of the carbazole class that exerts its therapeutic effects by inhibiting DNA topoisomerase I, preventing the DNA relaxation and replication necessary for cell division.… Read more
Rebeccamycin is an antitumor antibiotic of the carbazole class that exerts its therapeutic effects by inhibiting DNA topoisomerase I, preventing the DNA relaxation and replication necessary for cell division. As a potent cytotoxic agent, it is primarily studied in oncology for the treatment of various solid tumors through the poisoning of the topoisomerase I enzyme complex. This category provides access to high-quality reference standards for Rebeccamycin API, as well as its related impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous impurity profiling, method validation, and quality control. By utilizing these precisely characterized reference materials, researchers can ensure the accuracy and reliability of analytical testing throughout drug development and manufacturing processes.